mo:re

Germany - Hamburg

• 01/04/2025
• Seed
• $2,485,277

Your new teammate in the lab! Our lab platform takes over tedious and error-prone manual tasks in 3D cell culture, aiming to replace animal studies. A standardised repository of protocols lets you set up new experiments within minutes. Our AI-based quality control provides real-time transparency on the state of your cell culture, allowing you to worry less and make well-informed decisions.

Related People

Lukas GaatsFounder

Germany - Hamburg, Hamburg

Co-founder & CEO of mo:re, a biotechnology start-up building the new gold standard for organoid-based drug development by offering a lab platform that industrialises cell culture workflows.

Our platform of a lab robot and software replaces animal studies with AI-assisted cultivation of disease models on which new compounds can be tested in a standardised and high-throughput fashion. This enables scaling up experiments without compromising traceability and quality to bridge the gap between PoC and industry experiments.

Visit mo:re https://more.science

LinkedIn https://www.linkedin.com/in/lukas-gaats/?locale=en_US